Literature DB >> 25241062

GABAB1 and GABAB2 receptor subunits co-expressed in cultured human RPE cells regulate intracellular Ca2+ via Gi/o-protein and phospholipase C pathways.

Z-Y Cheng1, X-P Wang2, K L Schmid3, X-G Han4.   

Abstract

GABAB receptors associate with Gi/o-proteins that regulate voltage-gated Ca(2+) channels and thus the intracellular Ca(2+) concentration ([Ca(2+)]i), there is also reported cross-regulation of phospholipase C. These associations have been studied extensively in the brain and also shown to occur in non-neural cells (e.g. human airway smooth muscle). More recently GABAB receptors have been observed in chick retinal pigment epithelium (RPE). The aims were to investigate whether the GABAB receptor subunits, GABAB1 and GABAB2, are co-expressed in cultured human RPE cells, and then determine if the GABAB receptor similarly regulates the [Ca(2+)]i of RPE cells and if phospholipase C is involved. Human RPE cells were cultured from five donor eye cups. Evidence for GABAB1 and GABAB2 mRNAs and proteins in the RPE cell cultures was investigated using real time polymerase chain reaction, western blots and immunofluorescence. The effects of the GABAB receptor agonist baclofen, antagonist CGP46381, a Gi/o-protein inhibitor pertussis toxin, and the phospholipase C inhibitor U73122 on [Ca(2+)]i in cultured human RPE were demonstrated using Fluo-3. Both GABAB1 and GABAB2 mRNA and protein were identified in cell cultures of human RPE; antibody staining was co-localized to the cell membrane and cytoplasm. One-hundred micromolars of baclofen caused a transient increase in the [Ca(2+)]i of RPE cells regardless of whether Ca(2+) was added to the buffer. Baclofen-induced increases in the [Ca(2+)]i were attenuated by pre-treatment with CGP46381, pertussis toxin, and U73122. GABAB1 and GABAB2 are co-expressed in cell cultures of human RPE. GABAB receptors in RPE regulate the [Ca(2+)]i via a Gi/o-protein and phospholipase C pathway.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  G(i/o)-protein; GABA(B) receptor; calcium; phospholipase C; retinal pigment epithelium; γ-aminobutyric acid

Mesh:

Substances:

Year:  2014        PMID: 25241062     DOI: 10.1016/j.neuroscience.2014.09.021

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan.

Authors:  Shih-Yin Chen; Yuan-Man Hsu; Ying-Ju Lin; Yu-Chuen Huang; Chao-Jung Chen; Wei-De Lin; Wen-Lin Liao; Yng-Tay Chen; Wei-Yong Lin; Yu-Huei Liu; Jai-Sing Yang; Jinn-Chyuan Sheu; Fuu-Jen Tsai
Journal:  Biomedicine (Taipei)       Date:  2016-05-05

2.  Synthetic Fluorophores for Visualizing Biomolecules in Living Systems.

Authors:  V I Martynov; A A Pakhomov; N V Popova; I E Deyev; A G Petrenko
Journal:  Acta Naturae       Date:  2016 Oct-Dec       Impact factor: 1.845

3.  A Comprehensive Analysis Identified Hub Genes and Associated Drugs in Alzheimer's Disease.

Authors:  Qi Jing; Hui Zhang; Xiaoru Sun; Yaru Xu; Silu Cao; Yiling Fang; Xuan Zhao; Cheng Li
Journal:  Biomed Res Int       Date:  2021-01-09       Impact factor: 3.411

4.  GABAAα1 and GABAAρ1 subunits are expressed in cultured human RPE cells and GABAA receptor agents modify the intracellular calcium concentration.

Authors:  Zhen-Ying Cheng; Xu-Ping Wang; Katrina L Schmid; Xu-Guang Han; Hui Song; Xin Tang
Journal:  Mol Vis       Date:  2015-08-25       Impact factor: 2.367

5.  Meta-analysis of GABRB2 polymorphisms and the risk of schizophrenia combined with GWAS data of the Han Chinese population and psychiatric genomics consortium.

Authors:  Tian Zhang; Jun Li; Hao Yu; Yongyong Shi; Zhiqiang Li; Linyan Wang; Ziqi Wang; Tianlan Lu; Lifang Wang; Weihua Yue; Dai Zhang
Journal:  PLoS One       Date:  2018-06-12       Impact factor: 3.240

Review 6.  The Role of Phospholipase C in GABAergic Inhibition and Its Relevance to Epilepsy.

Authors:  Hye Yun Kim; Pann-Ghill Suh; Jae-Ick Kim
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.